| Item Type | Name |
|
Concept
|
gamma-Aminobutyric Acid
|
|
Concept
|
Cholesterol
|
|
Concept
|
Decision Support Techniques
|
|
Concept
|
Compassionate Use Trials
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Administration, Metronomic
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Brain Neoplasms
|
|
Academic Article
|
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic.
|
|
Academic Article
|
Severity of COVID-19 in patients with lung cancer: evidence and challenges.
|
|
Academic Article
|
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.
|
|
Academic Article
|
COVID-19 in patients with cancer: managing a pandemic within a pandemic.
|
|
Academic Article
|
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
|
|
Academic Article
|
Immunometabolic Status of COVID-19 Cancer Patients.
|
|
Academic Article
|
At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer.
|
|
Academic Article
|
Localized hand-foot syndrome after intra-arterial hepatic chemotherapy with floxuridine: a clinical case.
|
|
Academic Article
|
The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate.
|
|
Academic Article
|
Perioperative or postoperative therapy for resectable gastric cancer?
|
|
Academic Article
|
OncoAlert Round Table Discussions: The Global COVID-19 Experience.
|
|
Academic Article
|
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.
|
|
Academic Article
|
2020s Heroes Are Not Fearless: The Impact of the COVID-19 Pandemic on Wellbeing and Emotions of Italian Health Care Workers During Italy Phase 1.
|
|
Academic Article
|
Predicting response of molecular targeted therapies: a still possible challenge?
|
|
Academic Article
|
SMO mutations confer poor prognosis in malignant pleural mesothelioma.
|
|
Academic Article
|
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
|
|
Academic Article
|
ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?
|
|
Academic Article
|
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.
|
|
Academic Article
|
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy.
|
|
Academic Article
|
Predictive models in palliative care.
|
|
Academic Article
|
Caring for Patients With Cancer During the COVID-19 Outbreak in Italy.
|
|
Academic Article
|
Biological and clinical features in predicting efficacy of epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis.
|
|
Academic Article
|
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
|
|
Academic Article
|
RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.
|
|
Academic Article
|
Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders.
|
|
Academic Article
|
Cetuximab for metastatic colorectal cancer.
|
|
Academic Article
|
Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
|
|
Academic Article
|
Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey.
|
|
Academic Article
|
COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response.
|
|
Academic Article
|
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry.
|
|
Academic Article
|
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis.
|
|
Academic Article
|
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.
|
|
Academic Article
|
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study.
|
|
Concept
|
Pregabalin
|
|
Academic Article
|
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies.
|
|
Academic Article
|
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).
|
|
Academic Article
|
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
|
|
Academic Article
|
Response to Letter to the Editor From Shaorong Yu and Jifeng Feng.
|
|
Academic Article
|
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.
|